Main description:

Telemedicine has recently become a key focus of healthcare systems globally, heavily influenced by the COVID-19 pandemic and the increased need for remote care pathways. Implementing telemedicine can bring myriad benefits for both patients and providers, and has the potential to make a huge impact by improving access to abortion care.

In both the United Kingdom and United States, abortion is heavily regulated-exceptionally so when compared to other routine healthcare. This regulation has had the impact of exacerbating the social and geographical circumstances that can make access to abortion services difficult.

This book examines telemedical provision of early medical abortion, alongside the access barriers created by laws in the United Kingdom and United States. It critically appraises a series of developments in this rapidly evolving subject, providing an up-to-date and well-informed analysis. In doing so, it argues that there is a moral imperative to introduce, retain, or reinstate (as applicable) telemedical early medical abortion.

Contents:

Introduction
1: Understanding Early Medical Abortion
2: Abortion exceptionalism and the law in the United Kingdom and United States
3: Socio-legal barriers to early medical abortion
4: Piecemeal progression and home use of misoprostol in the United Kingdom
5: Early medical abortion and the telemedical imperative
6: A telemedical continuum for early medical abortion 183
7: The necessity of telemedical abortion during a pandemic
8: The legal and policy response to abortion care in the United Kingdom during COVID-19
9: Legal and policy restrictions on telemedical early medical abortion in the United States during COVID-19
Conclusion
Appendix - United Kingdom chronology
Appendix - United States chronology
Appendix - Demand-side TRAP laws in the United States
Appendix - Abortion provider restrictions in the United States
Appendix - State regulation of exchange health policies in the United States
Appendix - Limitations on the use of state funds in the United States
Appendix - State barriers to TEMA in the United States